Pain is a constant, complex companion that clinicians often struggle to understand and measure for people living with sickle ...

An in-depth review of chronic postfracture pain, detailing prevalence, modifiable risk factors (smoking, obesity), neural/molecular mechanisms, and assessment tools to support non-opioid analgesic ...

Treatment with upadacitinib was linked to reduced non-nociceptive pain among patients with axial spondyloarthritis, including both neuropathic and nociplastic pain. Treatment with upadacitinib is ...

From an etiological perspective, the International Association for the Study of Pain (IASP) classifies pain into three categories: nociceptive pain (NcP), neuropathic pain (NeP), and nociplastic pain ...

Researchers conducted a post hoc analysis to assess how upadacitinib affects both neuropathic and nociplastic pain scores over time. Treatment with upadacitinib was linked to reduced non-nociceptive ...

(RTTNews) - Artelo Biosciences, Inc. (ARTL), Monday, announced favorable results from its Phase 1 Single Ascending Dose or SAD clinical trial evaluating ART26.12, a first-in-class, orally administered ...

In 2023, nearly 1 in 4 US adults were living with chronic pain, and 8.5% experienced pain severe enough to limit daily life or work activities. This is up from 20% and 6.9% in 2020, respectively, and ...

Chronic pain affects over 50 million adults in the U.S. alone and is a leading cause of disability worldwide (Dahlhamer et al., 2018). Yet not all chronic pain is the same, and understanding what kind ...

A scientific statement has been published by the AHA regarding pain and treatment considerations in patients with PAD. The American Heart Association (AHA) has issued a scientific statement on ...